SLC34A3 and hypercalcemia disease: Treatment approaches included avoidance of sun exposure and vitamin D supplementation, sodium restriction and increased water intake, low calcium formula in one patient with symptomatic hypercalcemia (patient 1), citrate supplementation in patients with hypocitraturia, thiazide diuretics to reduce calciuria and phosphate supplementation in patients with SLC34A3 mutation.